Works matching IS 13524585 AND DT 2024 AND VI 30 AND IP 4/5


Results: 22
    1
    2
    3

    A custom-built step exergame training programme to prevent falls in people with multiple sclerosis: A multicentre randomised controlled trial.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 571, doi. 10.1177/13524585241229360
    By:
    • Hoang, Phu;
    • Sturnieks, Daina L;
    • Butler, Anna;
    • Chaplin, Carly;
    • Hicks, Cameron;
    • Lo, Joanne;
    • Ratanapongleka, Mayna;
    • Robinson, Sophie;
    • Smith, Natassia;
    • Turner, Jessica;
    • Krishnan, Arun V;
    • Barnett, Michael;
    • Gandevia, Simon;
    • Lord, Stephen R;
    • Menant, Jasmine C
    Publication type:
    Article
    4
    5
    6

    Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 558, doi. 10.1177/13524585241234783
    By:
    • Montalban, Xavier;
    • Piasecka-Stryczynska, Karolina;
    • Kuhle, Jens;
    • Benkert, Pascal;
    • Arnold, Douglas L;
    • Weber, Martin S;
    • Seitzinger, Andrea;
    • Guehring, Hans;
    • Shaw, Jamie;
    • Tomic, Davorka;
    • Hyvert, Yann;
    • Harlow, Danielle E;
    • Dyroff, Martin;
    • Wolinsky, Jerry S
    Publication type:
    Article
    7
    8

    EBV infection drives MS pathology: Yes.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 483, doi. 10.1177/13524585241235825
    By:
    • Aloisi, Francesca;
    • Salvetti, Marco
    Publication type:
    Article
    9

    EBV infection drives MS pathology: No.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 485, doi. 10.1177/13524585241235833
    By:
    • 't Hart, Bert A;
    • van Luijn, Marvin M
    Publication type:
    Article
    10
    11

    What contributes to disability in progressive MS? A brain and cervical cord–matched quantitative MRI study.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 516, doi. 10.1177/13524585241229969
    By:
    • Tur, Carmen;
    • Battiston, Marco;
    • Yiannakas, Marios C;
    • Collorone, Sara;
    • Calvi, Alberto;
    • Prados, Ferran;
    • Kanber, Baris;
    • Grussu, Francesco;
    • Ricciardi, Antonio;
    • Pajak, Patrizia;
    • Martinelli, Daniele;
    • Schneider, Torben;
    • Ciccarelli, Olga;
    • Samson, Rebecca S;
    • Wheeler-Kingshott, Claudia AM Gandini
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Use of pragmatic randomized trials in multiple sclerosis: A systematic overview.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 463, doi. 10.1177/13524585231221938
    By:
    • Hirt, Julian;
    • Janiaud, Perrine;
    • Düblin, Pascal;
    • Nicoletti, Giovanni Jacopo;
    • Dembowska, Kinga;
    • Nguyen, Thao Vy Thi;
    • Woelfle, Tim;
    • Axfors, Cathrine;
    • Yaldizli, Özgür;
    • Granziera, Cristina;
    • Kuhle, Jens;
    • Kappos, Ludwig;
    • Hemkens, Lars G
    Publication type:
    Article
    22

    An aggressive form of MOGAD treated with aHSCT: A case report.

    Published in:
    Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 612, doi. 10.1177/13524585231213792
    By:
    • Sbragia, Elvira;
    • Boffa, Giacomo;
    • Varaldo, Riccardo;
    • Raiola, Anna Maria;
    • Ghiso, Anna;
    • Gambella, Massimiliano;
    • Benedetti, Luana;
    • Angelucci, Emanuele;
    • Inglese, Matilde
    Publication type:
    Article